Swedish (OMX) Pharma Industry Analysis
UpdatedMay 20, 2024
DataAggregated Company Financials
Companies33
- 7D0.2%
- 3M15.4%
- 1Y63.2%
- YTD2.4%
Last week, the Pharma industry hasn't moved much but Calliditas Therapeutics is up 5.8% in that time. As for the the longer term, the industry is up 62% over the past 12 months. Looking forward, earnings are forecast to grow by 53% annually.
Industry Valuation and Performance
Has the Swedish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 20 May 2024 | kr53.4b | kr6.4b | -kr764,943,556.75 | 71.8x | -69.9x | 8.4x |
| Wed, 17 Apr 2024 | kr49.4b | kr6.2b | -kr1,040,636,941.51 | 75.6x | -47.5x | 7.9x |
| Fri, 15 Mar 2024 | kr50.7b | kr6.2b | -kr1,038,051,980.71 | 77.1x | -48.8x | 8.1x |
| Sun, 11 Feb 2024 | kr51.7b | kr6.0b | -kr906,523,947.19 | 66.4x | -57x | 8.6x |
| Tue, 09 Jan 2024 | kr69.3b | kr9.4b | -kr1,184,302,974.00 | 65.3x | -58.5x | 7.3x |
| Thu, 07 Dec 2023 | kr63.1b | kr9.5b | -kr1,209,390,321.00 | 57.2x | -52.2x | 6.7x |
| Sat, 04 Nov 2023 | kr53.9b | kr9.3b | -kr1,122,821,864.00 | 82.7x | -48x | 5.8x |
| Mon, 02 Oct 2023 | kr51.1b | kr9.2b | -kr1,177,247,599.00 | 122.3x | -43.4x | 5.6x |
| Wed, 30 Aug 2023 | kr50.9b | kr9.2b | -kr1,129,789,648.00 | 141.7x | -45x | 5.5x |
| Fri, 28 Jul 2023 | kr51.1b | kr8.8b | -kr1,370,087,011.00 | 71.8x | -37.3x | 5.8x |
| Sun, 25 Jun 2023 | kr48.4b | kr8.4b | -kr1,693,005,057.00 | 77x | -28.6x | 5.8x |
| Tue, 23 May 2023 | kr48.1b | kr8.4b | -kr1,693,488,615.00 | 82.6x | -28.4x | 5.8x |
| Thu, 20 Apr 2023 | kr45.7b | kr8.0b | -kr1,794,950,643.00 | 92.3x | -25.5x | 5.7x |
| Sat, 18 Mar 2023 | kr45.5b | kr8.0b | -kr1,793,487,114.00 | 83.8x | -25.4x | 5.7x |
| Mon, 13 Feb 2023 | kr47.3b | kr7.3b | -kr1,954,882,124.00 | 276.3x | -24.2x | 6.5x |
| Wed, 11 Jan 2023 | kr48.4b | kr7.3b | -kr1,910,843,928.00 | 292.9x | -25.3x | 6.6x |
| Fri, 09 Dec 2022 | kr50.0b | kr7.3b | -kr1,874,961,206.00 | 299.7x | -26.7x | 6.9x |
| Sun, 06 Nov 2022 | kr49.6b | kr7.0b | -kr1,764,362,038.00 | 44x | -28.1x | 7.1x |
| Tue, 04 Oct 2022 | kr49.7b | kr7.0b | -kr1,739,483,570.00 | 48.4x | -28.6x | 7.1x |
| Thu, 01 Sep 2022 | kr51.9b | kr7.0b | -kr1,745,888,578.00 | 58.7x | -29.7x | 7.5x |
| Sat, 30 Jul 2022 | kr51.8b | kr6.9b | -kr1,552,569,830.00 | 42.1x | -33.4x | 7.5x |
| Mon, 27 Jun 2022 | kr51.7b | kr5.9b | -kr1,509,116,648.00 | 44.4x | -34.3x | 8.7x |
| Wed, 25 May 2022 | kr51.7b | kr5.7b | -kr1,489,338,766.00 | 46.2x | -34.7x | 9.1x |
| Fri, 22 Apr 2022 | kr54.7b | kr5.5b | -kr1,335,933,728.00 | 37.7x | -41x | 9.9x |
| Sun, 20 Mar 2022 | kr54.2b | kr5.4b | -kr1,389,013,613.00 | 37.9x | -39x | 10x |
| Tue, 15 Feb 2022 | kr50.3b | kr5.3b | -kr1,078,929,318.00 | 139.8x | -46.6x | 9.5x |
| Thu, 13 Jan 2022 | kr52.7b | kr5.5b | -kr1,099,873,199.00 | 122.1x | -47.9x | 9.7x |
| Sat, 11 Dec 2021 | kr55.6b | kr5.5b | -kr1,097,650,781.00 | 125.3x | -50.7x | 10.2x |
| Mon, 08 Nov 2021 | kr53.0b | kr5.0b | -kr1,425,360,451.00 | 127.6x | -37.2x | 10.5x |
| Wed, 06 Oct 2021 | kr54.1b | kr4.8b | -kr1,582,269,890.00 | 149x | -34.2x | 11.3x |
| Fri, 03 Sep 2021 | kr58.0b | kr4.8b | -kr1,413,242,854.26 | 159.3x | -41x | 12.1x |
| Sun, 01 Aug 2021 | kr55.4b | kr4.8b | -kr1,412,039,942.26 | 171.4x | -39.3x | 11.6x |
Price to Earnings Ratio
-36.2x
Current Industry PE
- Investors are relatively neutral on the Swedish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 8.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | 0.43% | |
| Healthcare | -0.043% | |
| Pharma | 0.16% | |
| Pharma | 0.16% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CALTX Calliditas Therapeutics | kr117.20 | 1.6% +kr102.0m | 13.8% | PS5.2x | |
| ORX Orexo | kr21.15 | 11.3% +kr74.1m | 97.7% | PS1.2x | |
| CAMX Camurus | kr561.00 | 0.2% +kr57.6m | 109.3% | PE71.8x | |
| IBT B Infant Bacterial Therapeutics | kr96.60 | 3.4% +kr43.1m | 124.7% | PS18860x | |
| INDEX InDex Pharmaceuticals Holding | kr0.45 | 12.5% +kr26.6m | 12.8% | PS2.2x |